SD BioSensor, Inc
KRX:137310.KS
11460 (KRW) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -467,904.097 | 908,788.681 | 1,064,432.16 | 621,613.859 | 3,131.1 | 3,031.674 |
| Depreciation & Amortization
| 137,541.2 | 40,819.901 | 19,114.677 | 7,974.206 | 4,330.611 | 4,404.954 |
| Deferred Income Tax
| 0 | 0 | 224,140.711 | 126,606.585 | 0 | -142.106 |
| Stock Based Compensation
| 969.104 | 15,558.733 | 18,866.902 | 3,308.169 | 0 | 0 |
| Change In Working Capital
| 149,266.789 | -65,377.193 | -85,309.102 | -264,178.18 | -10,309.386 | -9,885.629 |
| Accounts Receivables
| 12,106.498 | 74,220.924 | 203,903.328 | -441,784.622 | 5,093.631 | -9,163.967 |
| Inventory
| 81,643.544 | -28,604.268 | 59,110.536 | -346,886.252 | -10,644.125 | -3,157.339 |
| Accounts Payables
| -31,005.768 | -36,683.027 | -304,204.705 | 428,502.769 | -5,719.636 | 1,952.919 |
| Other Working Capital
| 86,522.515 | -74,310.822 | -44,118.261 | 95,989.925 | 960.744 | 482.757 |
| Other Non Cash Items
| -62,191.509 | -9,556.759 | -6,300.297 | 57.054 | 1,222.898 | 20,806.86 |
| Operating Cash Flow
| -242,318.513 | 890,233.363 | 1,234,945.051 | 495,381.693 | -1,624.777 | -962.54 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| -142,565.918 | -300,451.246 | -99,293.783 | -55,149.402 | -7,502.743 | -2,329.068 |
| Acquisitions Net
| -1,748,594.875 | -47,154.492 | -36,764.214 | -909.589 | -4,724.269 | 12.855 |
| Purchases Of Investments
| -583,770.502 | -1,767,671.408 | -2,142,771.71 | -215,976.318 | -23,130 | -739.081 |
| Sales Maturities Of Investments
| 577,841.947 | 2,474,245.43 | 1,240,918.781 | 29,148.206 | 166.15 | 434.2 |
| Other Investing Activites
| -15,439.158 | -448.972 | 80,180.244 | -2,937.324 | -42.626 | 11.53 |
| Investing Cash Flow
| -1,912,528.505 | 358,519.312 | -957,730.681 | -245,824.427 | -35,233.488 | -2,609.564 |
| Financing Activities: | ||||||
| Debt Repayment
| 579,806.324 | -11,623.311 | -4,968.097 | -11,597.377 | 2,039 | 0 |
| Common Stock Issued
| 227,604.471 | 2,383.016 | 507,471.632 | -202.629 | 49,349.306 | 0 |
| Common Stock Repurchased
| 0 | 0 | -99,643.548 | 0 | 0 | 0 |
| Dividends Paid
| -29,549.598 | -198,735.12 | -49,924.925 | 0 | 0 | 0 |
| Other Financing Activities
| -8,099.096 | -17,761.423 | -404,069.654 | -2,863.571 | 51,562.654 | 0 |
| Financing Cash Flow
| 769,762.101 | -225,736.837 | 351,263.798 | -14,663.577 | 53,601.654 | 0 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| -5,475.92 | -31,665.223 | 9,898.978 | -10,877.45 | -210.083 | 0 |
| Net Change In Cash
| -1,390,560.837 | 991,350.614 | 638,377.146 | 224,016.238 | 16,533.306 | -3,572.104 |
| Cash At End Of Period
| 482,383.087 | 1,872,943.924 | 881,593.31 | 243,216.164 | 19,199.925 | 2,203.609 |